The pharma launchpad

Launches in oncology: The elements of success

– As the prevalence and severity of cancer has increased, the drug landscape has shifted. Oncology launches are increasingly critical and require a dedicated approach. Here’s what it entails.

How to make sure your next product or service launch drives growth

– Fifty percent of launches don’t hit their targets. Launch champions follow these four rules.

Why innovative products aren’t enough for a successful pharma launch

– In a tough launch environment, four executives share insights on how to set your company apart—with a laser focus on patients, an agile approach, and an engaged organization.

How to successfully launch a rare disease drug in a patient-centric world

– While all drug launches are complex, launches of rare disease treatments are particularly so. Our experience suggests that companies that launch rare disease treatments must excel in four areas.

Pharma’s next challenge

– Emerging markets are becoming ever more important for pharma. Yet to be successful, a rapid shift from a marketing and sales focus to an access-driven commercial model must occur.

Related insights

Pulling away from the pack in drug launches

– This analysis, published in Nature Reviews Drug Discovery, of US drug launches from the past decade indicates that commercial success has become more difficult to achieve, owing to factors such as increased competition, greater challenges in achieving therapeutic differentiation and payer pressures.

Five inconvenient truths that can make or break a product launch

– Understanding the basics of an agile pharma launch is one thing, but living them is something else altogether. A PM 360 piece examines ways your organization can build agility for launch efforts.